These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12054478)

  • 1. Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A.
    Katula KS; Fields A; Apple P; Rotruck T
    Arch Biochem Biophys; 2002 May; 401(2):271-6. PubMed ID: 12054478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition.
    Noh EJ; Lee JS
    Biochem Biophys Res Commun; 2003 Oct; 310(2):267-73. PubMed ID: 14521905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
    Xiao H; Hasegawa T; Isobe K
    J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response of the human cyclin B1 promoter to inhibitors of the cell cycle in NIH3T3 cells.
    Nuckolls FJ; Khan AS; Butler R; Katula KS
    Biochem Biophys Res Commun; 1998 Mar; 244(1):280-4. PubMed ID: 9514874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM; Soeth E; Smith CL
    Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
    Duan H; Heckman CA; Boxer LM
    Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA.
    Nair AR; Boersma LJ; Schiltz L; Chaudhry MA; Muschel RJ
    Cancer Lett; 2001 May; 166(1):55-64. PubMed ID: 11295287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.
    Ryu JK; Lee WJ; Lee KH; Hwang JH; Kim YT; Yoon YB; Kim CY
    Cancer Lett; 2006 Jun; 237(1):143-54. PubMed ID: 16009488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
    Kim YB; Lee KH; Sugita K; Yoshida M; Horinouchi S
    Oncogene; 1999 Apr; 18(15):2461-70. PubMed ID: 10229197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
    Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
    Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.
    Noh EJ; Lim DS; Jeong G; Lee JS
    Biochem Biophys Res Commun; 2009 Jan; 378(3):326-31. PubMed ID: 19038231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
    Adachi N; Nomoto M; Kohno K; Koyama H
    Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 gene regulation during enterocyte differentiation.
    Archer SY; Johnson JJ; Kim HJ; Hodin RA
    J Surg Res; 2001 Jun; 98(1):4-8. PubMed ID: 11368530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.